Clinical Trial Update: Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating nitric oxide therapy in COVID-19 patients requiring oxygen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Hypoxemia
• Pneumonia Viral

Drugs mentioned

• nitric oxide therapy (nitric oxide)

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Hypoxemia, Pneumonia, Viral | Phase 1, Phase 2 | Status: COMPLETED